ReviewCurrent opinion in chemical biology2012
Lipidomics: when apocrypha becomes canonical.
Review in Current opinion in chemical biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat.BMC complementary medicine and therapies · 2021Article
- Significance of long chain polyunsaturated fatty acids in human health.Clinical and translational medicine · 2017Review
- Use of Fibonacci numbers in lipidomics - Enumerating various classes of fatty acids.Scientific reports · 2017Article
- Regulation of gene expression through a transcriptional repressor that senses acyl-chain length in membrane phospholipids.Developmental cell · 2014Article
- Metaorganismal nutrient metabolism as a basis of cardiovascular disease.Current opinion in lipidology · 2014Review
- Sum of the parts: mass spectrometry-based metabolomics.Biochemistry · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Lipidomics is a branch of the field of metabolomics. Although only about a decade since its inception, lipidomics has already had a major influence on the way in which questions about lipid metabolism and signaling are posed. The field is intertwined in the culture and rich history of mass spectrometry. Early work emphasized analytical issues such as limits of detection and numbers of molecular species quantitated in single injections. Increased sophistication in applications of lipidomic analysis and emerging technologies, such as imaging mass spectrometry, are facilitating the study of lipid metabolism and signaling species in cellular functions and human diseases. In the coming years we anticipate a richer understanding of how specific lipid species mediate complex biological processes and interconnections between cellular pathways that were thought to be disparate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.